June 11, 2014 at 13:37 PM EDT
Losses extended over global economic concerns

The markets extended its losses during the midday with the Dow dropping 87 points to 16,858 over concerns of a global economic slowdown. Nasdaq slipped 3 points to 4,334.

On the upside

Norhtwest Biotherapeutics (Nasdaq: NWBO) reported positive results from an ongoing Phase I/II trial of its cancer treatment DCVax-Direct.

Montage Technology (Nasdaq: MONT) agreed to be acquired by Shanghai Pudong Science and Technology Investment for a premium of approximately $693 million.

Bank of America/Merrill Lynch upgraded Micron Technology (Nasdaq: MU) from an Underperform rating to a Buy rating.

On the downside

Auxilium Pharmaceuticals (Nasdaq: AUXL) partnered with Prasco to launch a generic version of its testosterone gel Testim.

United Natural Foods (Nasdaq: UNFI) reported higher third quarter earnings and revenue but the company forecast full year earnings below estimates.

A profit warning by Lufthansa weighed down share of Delta Airlines (NYSE: DAL).

In the broad market, declining issues outpaced advancers by a margin of nearly 2 to 1 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 lost 5 points to 1944. Bitcoin slipped $4.87 or 0.75% to $646.24.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here